From Hype to Returns How Enterprises Are Navigating the AI ROI Challenge Retail Sales Post Solid Gain Yet Early Signals of Consumer Pullback Emerge USIran Tensions Snowflake Earnings Surge Robinhood AI Tools Lead Market Movers The Mandalorian And Grogu Sets a Rotten Tomatoes Audience Score Record Diverging From Critical Reception Evaluating Wall Streets Outlook on Intuit Stock Senegals Debt Crisis Deepens as President Sacks Prime Minister and Dissolves Government AGRO Q1 2026 Earnings Significant EPS Miss but Stock Rises Star Equity Holdings Inc STRR Q1 2026 Earnings Significant EPS Miss Amid Operational Challenges Taylor Devices Inc TAYD Q1 2026 Earnings Earnings Beat Drives Modest Share Price Gain AMPH Q1 2026 Earnings EPS Misses Estimates as Amphastar Faces Operational Pressures Compass COMP Q1 2026 Earnings EPS Beats Estimates by Wide Margin Despite Revenue Uncertainty Milestone Pharmaceuticals Q1 2026 Earnings ClinicalStage Biotech Reports Wider Loss Than Expected NeOnc Technologies NTHI Edges Lower but Holds Above Key Support as Trading Volume Remains Subdued BeOne Medicines ONC Edges Higher Amid Sector Volatility Key Levels in Focus PLBY Retreats to 128 Bearish Momentum Tests Critical Support Mannatech MTEX Surges 288 as Stock Tests Key Resistance Levels Comstock Holding Companies CHCI Surges 74 as Stock Tests Key Resistance Near 1560 Should You Let a Prospective Employer Contact Your Current Boss Key Considerations for Job Seekers ASRV Q1 2026 Earnings Stable EPS at 011 Amidst Flat Market Response SOHOO Preferred Stock Holds Near Support Amid Minimal Movement MCN Dip XAI Madison Equity Premium Income Fund Sees Minor Pullback Amid Steady Range GCM Grosvenor GCMG Slips Slightly as Resistance Caps NearTerm Upside Scienjoy Holding SJ Rises 242 as Stock Tests Key Resistance Level Lotus Technology LOT Slips 074 as Stock Hovers Near Support Key Levels in Focus Evotec ADR Slides 43 as Selling Pressure Tests Key Support Levels Karooooo Ltd KARO Holds Steady Near Support as Mild Decline Suggests Consolidation FibroBiologics FBLG Holds Steady at 105 as Biotech Sector Awaits Catalyst